Compare Stocks

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DR Medical Facilities	C$10.96 -0.8%	C$10.24	C$7.82 ▼ C$11.24	C$270.93M	0.59	59,874 shs	67,210 shs
GHG GreenTree Hospitality Group	$2.86 -1.4%	$3.12	$2.72 ▼ $6.78	$292.23M	0.72	5,658 shs	13,927 shs
ITMR Itamar Medical	$30.87	$30.75	$16.36 ▼ $30.91	$497.25M	0.73	90,796 shs	N/A
NBSE NeuBase Therapeutics	$0.44 +5.0%	$0.69	$0.39 ▼ $4.80	$1.66M	0.83	202,576 shs	25,441 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DR Medical Facilities	-0.81%	+0.36%	+7.59%	+11.96%	+30.31%
GHG GreenTree Hospitality Group	+1.15%	+4.76%	-5.52%	-4.35%	-28.87%
ITMR Itamar Medical	0.00%	0.00%	0.00%	0.00%	0.00%
NBSE NeuBase Therapeutics	0.00%	+0.26%	-57.44%	-32.12%	-83.97%

Mysterious Gold Leverage Just Announced (Ad)

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DR Medical Facilities	0.1652 of 5 stars	1.0	0.0	1.7	0.0	1.1	0.0	1.3
GHG GreenTree Hospitality Group	1.3159 of 5 stars	2.5	3.0	0.0	0.0	1.1	1.7	1.3
ITMR Itamar Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DR Medical Facilities	2.00	Hold	C$12.00	9.49% Upside
GHG GreenTree Hospitality Group	1.00	Sell	$4.00	39.86% Upside
ITMR Itamar Medical	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ITMR, DR, RAP, GHG, and NBSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/15/2024	DR Medical Facilities	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform	C$11.00 ➝ C$12.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DR Medical Facilities	C$445.58M	0.61	C$2.38 per share	4.60	C$3.48 per share	3.15
GHG GreenTree Hospitality Group	$1.08B	0.27	$0.51 per share	5.63	$2.03 per share	1.41
ITMR Itamar Medical	$41.03M	12.12	N/A	N/A	N/A	∞
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	$11.04 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DR Medical Facilities	C$18.50M	C$1.00	10.96	∞	3.81	4.15%	37.77%	11.45%	5/9/2024 (Estimated)
GHG GreenTree Hospitality Group	$37.44M	N/A	0.00	7.33	N/A	N/A	N/A	N/A	N/A
ITMR Itamar Medical	N/A	-$1.35	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	-$4.37M	-$7.70	N/A	∞	N/A	N/A	-99.74%	-60.13%	5/9/2024 (Estimated)

Latest ITMR, DR, RAP, GHG, and NBSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/25/2024	Q4 2023	GHG GreenTree Hospitality Group	-$0.02	$0.01	+$0.03	$0.01	$57.94 million	$52.42 million
3/14/2024	Q4 2023	DR Medical Facilities	N/A	C$0.53	+C$0.53	C$0.53	C$151.52 million	C$166.47 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DR Medical Facilities	C$0.32	2.92%	N/A	32.00%	N/A
GHG GreenTree Hospitality Group	$0.53	18.53%	N/A	N/A	N/A
ITMR Itamar Medical	N/A	N/A	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	N/A	N/A	N/A	N/A

Latest ITMR, DR, RAP, GHG, and NBSE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/19/2024	DR Medical Facilities	Quarterly	C$0.08	3.05%	3/27/2024	3/28/2024	4/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DR Medical Facilities	98.74	1.24	1.51
GHG GreenTree Hospitality Group	0.04	1.21	1.20
ITMR Itamar Medical	N/A	N/A	N/A
NBSE NeuBase Therapeutics	N/A	2.87	2.87

Ownership

Institutional Ownership

Company	Institutional Ownership
DR Medical Facilities	4.82%
GHG GreenTree Hospitality Group	8.05%
ITMR Itamar Medical	42.19%
NBSE NeuBase Therapeutics	12.37%

Insider Ownership

Company	Insider Ownership
DR Medical Facilities	0.41%
GHG GreenTree Hospitality Group	88.70%
ITMR Itamar Medical	N/A
NBSE NeuBase Therapeutics	13.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DR Medical Facilities	1,833	24.72 million	N/A	Not Optionable
GHG GreenTree Hospitality Group	2,063	102.18 million	11.55 million	Not Optionable
ITMR Itamar Medical	257	16.11 million	N/A	Not Optionable
NBSE NeuBase Therapeutics	37	3.75 million	3.23 million	Not Optionable

ITMR, DR, RAP, GHG, and NBSE Headlines

Source	Headline
	NeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaq finanznachrichten.de - April 6 at 8:58 AM
	NeuBase Therapeutics Announces Receipt of Notice from Nasdaq globenewswire.com - April 5 at 4:05 PM
	Once-promising Pittsburgh biotech firm shutting down for good technical.ly - March 27 at 8:33 PM
	Why Neubase Therapeutics (NBSE) Shares Are Nosediving msn.com - March 27 at 10:32 AM
	NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers msn.com - March 26 at 10:47 AM
	Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today? investorplace.com - March 26 at 9:08 AM
	NeuBase Therapeutics sets shareholder meeting on dissolution plan bizjournals.com - March 25 at 7:44 PM
	NeuBase Therapeutics Inc edition.cnn.com - February 26 at 9:46 AM
	NeuBase Therapeutics, Inc. (NBSE) finance.yahoo.com - February 20 at 1:40 PM
	NeuBase Therapeutics Inc (O7P.BE) ca.finance.yahoo.com - January 20 at 12:17 AM
	Monitoring NeuBase Therapeutics Inc (NBSE) after recent insider movements knoxdaily.com - January 1 at 2:48 PM
	CMU halts licensing agreement with NeuBase Therapeutics bizjournals.com - December 22 at 7:16 PM
	Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance finance.yahoo.com - November 27 at 10:19 AM
	NeuBase Therapeutics Inc NBSE morningstar.com - November 6 at 11:41 PM
	NeuBase Therapeutics: Other Events cbonds.com - October 21 at 8:32 AM
	NeuBase Therapeutics, Inc. (NBSE.MX) finance.yahoo.com - October 6 at 8:56 AM
	NeuBase Therapeutics Inc. (NBSE) gets rating Reiterated from H.C. Wainwright knoxdaily.com - September 20 at 6:31 PM
	Massive Insider Trade At NeuBase Therapeutics benzinga.com - September 12 at 3:51 PM
	NeuBase falls after largest shareholder disposes of part stake msn.com - September 12 at 3:51 PM
	NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder finance.yahoo.com - September 8 at 11:10 AM
	Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today? markets.businessinsider.com - September 6 at 9:07 AM
	NBSE’s short interest falls to 41130.0 shares knoxdaily.com - August 25 at 4:34 PM
	Analysts Conflicted on These Healthcare Names: NeuBase Therapeutics (NBSE) and Centessa Pharmaceuticals (CNTA) markets.businessinsider.com - August 16 at 7:45 AM
	NeuBase Therapeutics (NASDAQ: NBSE) fool.com - August 6 at 6:46 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 3, 2024 6:20 AM
View Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
3 High Dividend Stocks to Replace Lower Savings Yields Ahead
April 9, 2024 9:15 AM
View 3 High Dividend Stocks to Replace Lower Savings Yields Ahead
3 Key Stocks Helping to Drive the EV Race
April 12, 2024 9:25 AM
View 3 Key Stocks Helping to Drive the EV Race
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
It’s Time to Buy Into the Super Micro Computer Stock Implosion
April 22, 2024 12:33 PM
View It’s Time to Buy Into the Super Micro Computer Stock Implosion

All Headlines

Company Descriptions

Medical Facilities

TSE:DR

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States. The company's specialty hospital offers non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as primary and urgent care; and ambulatory surgery centers offers scheduled outpatient surgical procedures. Medical Facilities Corporation was incorporated in 2004 and is headquartered in Toronto, Canada.

GreenTree Hospitality Group

NYSE:GHG

GreenTree Hospitality Group Ltd., through its subsidiaries, develops leased-and-operated, and franchised-and-managed hotels under the GreenTree Inns brand in the People's Republic of China. It also engages in investment holding activities; and provision of information technology services. The company was founded in 2004 and is headquartered in Shanghai, the People's Republic of China.

Itamar Medical

NASDAQ:ITMR

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

NeuBase Therapeutics

NASDAQ:NBSE

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial